Infrastructure

State of Art R&D and Manufacturing facility for Pharmaceutical Formulations and Pharmaceutical Active Ingredients.

At Cyma Lifesciences Private Limited, our R&D and manufacturing infrastructure is a testament to our dedication to innovation, quality, and efficiency. Spread over 27,000 square meters, with a built-up area of 8,100 square meters, our facility is designed to meet the demands of modern pharmaceutical development and manufacturing. Equipped with state-of-the-art process-controlled, high-capacity machinery, we are capable of producing 1,350 tonnes of pellets annually, with provision for the production of 720 tonnes of DC Granules and a wide variety of customer-required formulations.

Our facilities are built to seamlessly manage the entire pharmaceutical formulation process, from development to large-scale production, ensuring consistency and quality at every step. This scale-up capability allows us to transition effortlessly from small-scale development to commercial production, providing flexibility to meet our clients’ specific needs.

180 Sq Mtr

Dedicated R&D Space

9,000 Sq Mtr

Build-up Area

Modified Release Pellets
We specialize in the customized development and manufacture of modified-release pellets, tailored to meet diverse pharmaceutical needs.
Robust Scale-Up
Our extensive scale-up capabilities ensure the smooth transition from research and development to full-scale production without compromising quality or timelines.
Customer-Centric Focus
Through our Customer Relationship Management (CRM) systems, we are dedicated to meet the quality, cost efficiency and timelines as per the requirements of our clients.